1PARKIN D M,BRAY F.Chapter 2:The burden of HPV-ralated cancers[J].Vaccine,2006,24(Suppl 3):S3,S11-S25.
2MU(N)OZ N,BOSCH F X,DE SANJOS(E) S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer[J].N Engl J Med,2003,348(6):518-527.
3LI C,WU M,WANG J,et al.A population-based study on the risks of cervical lesion and human papillomavirus infection among women in Beijing,People′s Republic of China[J].Cancer Epidemiol Biomarkers Prev,2010,19(10):2655-2664.
4HLAING T,YIP Y C,NGAI K L,et al.Distribution of human papillomavirus genotypes among cervical intraepithelial neoplasia and invasive cancers in Macao[J].J Med Virol,2010,82(9):1600-1605.
5KOUTSKY L A,AULT K A,WHEELER C M,et al.A controlled trial of a human papillomavirus type 16 vaccine[J].N Engl J Med,2002,347(21):1645-1651.
6MAO C,KOUTSKY L A,AULT K A,et al.Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia:a randomized controlled trial[J].Obstet Gynecol,2006,107(1):18-27.
7FUTURE Ⅰ/Ⅱ Study Group,DILLNER J,KJAER S K,et al.Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical,vulvar,and vaginal intraepithelial neoplasia and anogenital warts:randomised controlled trial[J].BMJ,2010,341:C3493.
8PAZ DE LA ROSA G,MONROY GARC(I)A A,MORA GARC(I)A MDE L,et al.An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice[J].Virol J,2009,6:2.
9FRAILLERY D,BAUD D,PANG S Y,et al.Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever[J].Clin Vaccine Immunol,2007,14(10):1285-1295.
10LIU D W,CHANG J L,TSAO Y P,et al.Co-vaccination with adeno-associated virus vectors encoding human papillomavirus 16 L1 proteins and adenovirus encoding murine GM-CSF can elicit strong and prolonged neutralizing antibody[J].Int J Cancer,2005,113(1):93-100.
9Parkin D M, Bray F, Chapter . The burden of HPV - re- lated cancers[ J]. Vaccine, 2006, 24 ( Suppl 3), S11 - $25.
10Shi J F, Belinson J L, Zhao F H,et al. Human papillo- mavirus testing for cervical cancer screening: results from a 6 -year prospective study in rural china[J]. Am J Epidemiology,2009,170(6) :708 -716.
